Dudediligence.

TriSalus Life Sciences, Inc

TLSINASDAQ · Surgical & Medical Instruments & Apparatus
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$7.3MSep ’24$8.3MDec ’24$9.2MMar ’25$11.2MJun ’25$11.6MSep ’25$13.2MDec ’25$8.9MMar ’26$11.4MJun ’26
Net income, by quarter
−$2.4MSep ’24−$10.1MDec ’24−$10.4MMar ’25−$8.3MJun ’25−$10.8MSep ’25−$9.8MDec ’25$1.5MMar ’26−$9.2MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on file$12.4M$18.5M$29.4M$45.2M
Gross profitnone on file$10.1M$15.9M$25.3M$38.2M
Operating income−$3.0M−$36.4M−$54.5M−$36.2M−$26.9M
Net income$4.8M−$47.2M−$59.4M−$30.0M−$39.2M
Operating cash flow−$1.7M−$32.3M−$50.6M−$40.8M−$18.0M
Free cash flownone on file−$33.0M−$51.2M−$41.2M−$18.9M
Cash$200,884$9.4M$11.8M$8.5M$20.4M
Debtnone on filenone on file$0.00$22.1M$33.0M
Shares outstandingnone on file347.9K26.4M31.3M50.0M